Site #231 — Staten Island, New York

Site #231 is a clinical research site located in Staten Island, New York, United States 10312.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Site #231 has participated in 2 clinical trials.

Therapeutic areas: Antipsychotic-induced Weight Gain (AIWG).

Sponsors: Corcept Therapeutics.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Staten Island

Browse all research sites in New York · View every site in Staten Island

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site #231?

Site #231 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site #231 conducted?

Site #231 has 2 clinical trials on record. Their work covers Antipsychotic-induced Weight Gain (AIWG).

Is Site #231 accredited by Crixeo Clinical Trials?

Site #231 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site #231?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.